Focusing on technologies that help prevent, diagnose and treat diseases

The Capricorn Health-tech Fund focuses on non-digital technologies that help prevent, diagnose and treat diseases (while the Capricorn Digital Growth Fund focuses on digital health technologies). The human healthcare technology sector comprises a diverse range of products and services in sub-sectors such as biopharmaceutical and pharmaceutical drugs, vaccines, medical devices, medical imaging, diagnostics, research equipment and nutraceuticals.

The fund has € 42 million committed capital and is fully invested

Mainstay Medical

Medical Devices
Rehabilitative treatment for severe low back pain

Mainstay Medical

iSTAR Medical

Medical Devices
Implants for patients with glaucoma

iSTAR Medical

Confo Therapeutics

Platform Technology
Stabilize, target, discover and transform

Confo Therapeutics

Digital Health Companies are supported via Capricorn Digital

Encouraging the development of medical procedures and drugs for emerging countries and ageing populations
Jos B. Peeters

Ambition

Our ambition is to encourage the development of novel medical procedures and drugs, which meet a major demand in all economies. On the one hand, this demand is fueled by the global increase in life expectancy which has created an elderly Western population struggling with chronic diseases. The rise in lifespan will continue to present significant growth opportunities for human healthcare technology companies. On the other hand, the Capricorn Health-tech Fund responds to the fact that more people in emerging economies can now afford proper medical treatment.

Our values in numbers

0 7 total
investments
0 42 M€
commited capital
0 3 companies
exited